Abstract
Thyroid ophthalmopathy is a part of the presentation of Graves’ disease in many, but not all, patients and can also occur or worsen after treatment. It has an autoimmune etiology. Clinical findings may include proptosis, diplopia, periorbital edema, conjunctival injection, chemosis, dry and painful eyes, and occasionally loss of vision. In most cases, thyroid eye findings are mild and stabilize after treatment. However, some patients develop severe proptosis, eye muscle problems, and even optic nerve compression, and require aggressive treatment. The cases discussed in this chapter demonstrate some of these problems and an approach to management.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Selected Sources
Asman P. Ophthalmological evaluation in thyroid-associated ophthalmopathy. Acta Ophthalmol Scand 2003;81:437–448
Bartalena L, Tanda ML, Piantanida, E, Lai A, Pinchera A. Relationship between management of hyperthyroidism and course of the ophthalmopathy. J Endocrinol Invest 2004;27:288–294.
El Kaissi S, Frauman AG, Wall JR. Thyroid-associated ophthalmopathy: a practical guide to classification, natural history and management. Intern Med J 2004;34:482–491.
Hatton MP, Rubin PA. The pathophysiology of thyroid-associated ophthalmopathy. Ophthalmol Clin North Am 2002;15:113.
Perros P, Kendall-Taylor P. Medical treatment for thyroid-associated ophthalmopathy. Thyroid 2002;12:241–244.
Rights and permissions
Copyright information
© 2005 Humana Press Inc., Totowa, NJ
About this chapter
Cite this chapter
(2005). Thyroid Ophthalmopathy. In: Thyroid Disease. Current Clinical Practice. Humana Press. https://doi.org/10.1385/1-59259-944-3:043
Download citation
DOI: https://doi.org/10.1385/1-59259-944-3:043
Publisher Name: Humana Press
Print ISBN: 978-1-58829-534-7
Online ISBN: 978-1-59259-944-8
eBook Packages: MedicineMedicine (R0)